GlassScriptPrepare for your visit
Jitendra I Patel
Pulmonary Disease · Marion, IN · NPI 1821192253
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$166.80
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 5 by amount.
- Actelion Pharmaceuticals US, INC. $56.88
- Boehringer Ingelheim Pharmaceuticals, INC. $47.10
- Janssen Pharmaceuticals, INC $26.70
- Astrazeneca Pharmaceuticals LP $23.12
- Glaxosmithkline, LLC. $13.00
Questions you might ask
- I saw Jitendra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1184018/jitendra-i-patel